Hot melt tts for administering rotigotine
3 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to a transdermal therapeutic system (TTS) which contains a rotigotine-containing adhesive layer and is characterized by the fact that the adhesive layer contains a hot-meltable contact adhesive. The invention also relates to the use of rotigotine for producing the adhesive layer of a TTS in a hot melt method, and a method for producing such a TTS.
149 Citations
59 Claims
-
1-27. -27. (canceled)
-
28. A transdermal therapeutic system comprising a drug-containing adhesive matrix, in which the drug is Rotigotine ((−
- )-5,6,7,8-tetrahydro-6-[propyl[2-(2- thienyl)ethyl)amino]-1-naphthol) or a prodrug of Rotigotine,
wherein the adhesive matrix contains a hot-meltable adhesive, the hot-meltable adhesive consisting of one adhesive or a mixture of different adhesives or of a mixture of an adhesive and a softener and exhibiting at 160°
C. a dynamic viscosity of not more than 100 Pa·
s. - View Dependent Claims (29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)
- )-5,6,7,8-tetrahydro-6-[propyl[2-(2- thienyl)ethyl)amino]-1-naphthol) or a prodrug of Rotigotine,
-
45. A transdermal therapeutic system for administration of Rotigotine, comprising:
-
a layer that comprises Rotigotine or a prodrug of Rotigotine, wherein the layer (a) contains Rotigotine or prodrug thereof in a percentile proportion of at least 20 weight %, (b) has a Rotigotine or prodrug thereof content of at least 2.0 mg/cm2, and (c) optionally contains an organic wax and/or internal-phase component in an amount sufficient to retard the release of the active substance. - View Dependent Claims (46, 47, 48, 49, 50, 51)
-
-
52. A method for producing a transdermal therapeutic system that encompasses an adhesive matrix comprises Rotigotine or a prodrug of Rotigotine as the drug, the method comprising:
prior to lamination components of the adhesive matrix are melted and homogenized, solvent-free, at temperatures of between 70°
C. and 200°
C.- View Dependent Claims (53, 54, 55, 56, 57, 58, 59)
Specification